THE Scope of the Proposed Program Includes Manufacture of Sabin?s Sudan Ebolavirus Vaccine (bulk Drug Substance (BDS) and Final Drug Product (FDP)) to Provide Doses That MAY BE Used in the Event of an Outbreak Scenario. the Proposed Effort Will Utili
Contract Overview
Contract Amount: $158,810,481 ($158.8M)
Contractor: Albert B. Sabin Vaccine Institute, Inc. (THE)
Awarding Agency: Department of Health and Human Services
Start Date: 2022-12-29
End Date: 2030-09-30
Contract Duration: 2,832 days
Daily Burn Rate: $56.1K/day
Official Description: THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE DOSES THAT MAY BE USED IN THE EVENT OF AN OUTBREAK SCENARIO. THE PROPOSED EFFORT WILL UTILI
Place of Performance
Location: District of Columbia, 20037